LANSOPRAZOLE vs LAROTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LANSOPRAZOLE vs LAROTRECTINIB: Safety Overview
| Metric | LANSOPRAZOLE | LAROTRECTINIB |
|---|---|---|
| Total FAERS Reports | 60,931 | 798 |
| Deaths Reported | 6,896 | 149 |
| Death Rate | 11.3% | 18.7% |
| Hospitalizations | 12,277 | 151 |
| Average Patient Age | 60.3 yrs | 48.9 yrs |
| % Female Patients | 57.3% | 51.5% |
| FDA Approval Date | Apr 23, 2010 | Nov 26, 2018 |
| Manufacturer | Ascend Laboratories, LLC | Bayer HealthCare Pharmaceuticals Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |